Lifecore Biomedical (LFCR) Stock Statistics & Valuation Metrics

Lifecore Biomedical has a market cap or net worth of $164.29M. The enterprise value is $293.64M.

Lifecore Biomedical has 37,509,407 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lifecore Biomedical’s return on equity (ROE) is -28.98 and return on invested capital (ROIC) is -8.10%.

The current PE Ratio of Lifecore Biomedical is ―. Lifecore Biomedical’s PEG ratio is 0.01.

In the last 12 months, Lifecore Biomedical had revenue of 128.87M and earned -38.72M in profits. Earnings per share was -1.27.

In the last 12 months, operating cash flow was 17.38M and capital expenditures -6.91M, giving a free cash flow of 10.47M billion.

Lifecore Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Lifecore Biomedical upcoming earnings date is Aug 6, 2026, After Close (Confirmed).

Lifecore Biomedical as a current ratio of 2.84, with Debt / Equity ratio of 722.60%

In the past 12 months, Lifecore Biomedical has paid 43.00K in taxes.

Lifecore Biomedical EV to EBITDA ratio is -40.46, with an EV/FCF ratio of -26.18.

Lifecore Biomedical has $20.80M in cash and marketable securities with $150.14M in debt, giving a net cash position of -$129.35M billion.

Gross margin is 31.17%, with operating margin of -13.38%, and net profit margin of -30.04%.

The average price target for Lifecore Biomedical is $6.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy